Show results for
Refine by
Obesity Suppliers In Canada
5 companies found
based inUnionville, ONTARIO (CANADA)
As the first company to bring point-of-care autologous cell therapy to Canadians, MDBiologix is a pioneer in the field of Regenerative Medicine with over 20+ years of industry experience. We are a privately held, family-run business that is ...
Marrow Cellution™ bone graft kits provide high quality bone marrow aspirate and cancellous bone autograft, collected from numerous sites within the marrow space – achieving the gold standard of autograft in a minimally invasive ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Since 1990, Aurora has been serving the global scientific research community through the development of innovative laboratory solutions. Headquartered in Vancouver, Canada, the company started manufacturing analytical instrumentation based on a ...
based inCrystal Lake, ILLINOIS (USA)
X-Ray Cassette Repair Company, Inc., d.b.a. Reina Imaging was founded in 1978 by the current President and C.E.O. Leo Reina R.T. With his years of experience working as both a radiographer and serving as department manager for six years at Lee ...
TheWeight Distribution Capis designed to protect your expensive and fragile DR panel from direct patient weight during standing feet exams. This cap features slip-resistant feet, cutouts for any tether, and it can withstand up to 750lb due to its ...
based inLaval, QUEBEC (CANADA)
Maranda Lauzon is a family owned and operated business, specializing in the distribution of products and services in the medical imaging industry for more than 35 years. Throughout the years, we have built a solid reputation for the diversity of our ...
based inMontreal, QUEBEC (CANADA)
As a specialty therapeutics, clinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of diabetic kidney disease, type 1 and type 2 diabetes, ...
CB1 receptor world expert Dr George Kunos from US NIH has extensively demonstrated that peripherally-acting CB1 blockade provides an equivalent therapeutic potential to treat metabolic conditions such as obesity/NASH/T2D and ...